Category: Intravenous Therapy

There is good scientific evidence the lead [i] and mercury [ii] can cause atherosclerosis. A recent review article published in the Journal of the American heart association[iii] sheds a positive light on EDTA chelation therapy for patients with cardiovascular disease. [1]  In the most comprehensive systemic review and meta-analysis to date, Ravalli et. al evaluated 24 published studies on EDTA chelation. This article is noteworthy because it’s the largest review to date including 15 before and after chelation clinical trials and five retrospective case series. The effect of EDTA was also factored in to determine if the clinical effects of EDTA are more pronounced in patients with existing diabetes and arterial disease. The authors concluded that EDTA chelation can eliminate the toxic metals that are associated with inflammatory oxidative damage to the artery wall and atherosclerosis. Just as in other studies they found that chelation had more benefit for patients with comorbidities. Comorbidities are conditions that increase risk of heart attack and stroke such as diabetes and peripheral arterial disease. The higher your risk the greater the benefit from chelation. How Chelation Therapy Works for Heart Disease The main way chelation works for heart disease is through removing toxic metals...

Intravenous (IV) therapy is when a substance or drug is administered to a patient directly into the vein. Over the last 15 years, it has become very clear that IV treatments can help improve cold/flu symptoms, recovery, hangovers, and fatigue. Some intravenous treatments are approved by the FDA for the treatment of conditions such as heavy metal poisoning, dehydration, and nutritional deficiency. The benefits of IV therapy include: Nutrients go right into the bloodstream Nutrients bypass the gut and avoid absorption issues Higher doses of nutrients can be delivered with greater tolerance Therapeutic doses of nutrients can be given Doses can be given quickly IV therapy is an excellent way to get nutrients and hydration whether it be for optimizing health or restoring health. It has been hypothesized that as low as 10% and as much as 80% of our nutrients are absorbed from the food we eat. The factors that impact your nutrient status are: Diseases of the digestive system such as IBS, Crohns, Ulcers, GERD, and Gastric bypass High level athletic training Menstrual irregularities and heavy menstrual cycles Infections Poor dietary intake of nutrients Is IV Therapy Safe? Generally speaking, IV vitamins and minerals are safe for most...

Hydration is a key element in performance and recovery for athletes. The total percent of water in the human body is affected by how much body fat you have, as well as your age, gender, and health. However, on average the human body is about 45-70% water, which amounts to 40-45 liters of water in the body (165 x 8-ounce glasses of water!). There are two compartments that house this water, one is intracellular, inside cells where 62-65% of the water is found, and the other is extracellular, outside cells such as the blood and GI tract where 35-38% is found. Whether it is hot or cold out, when you exercise you lose water through breathing, muscle contraction, blood circulating, and sweating. Most people know that lack of fluids and lots of physical training can cause dehydration, but did you know that traveling also causes dehydration? Why traveling causes dehydration: People drink less water with the limitations around fluids and flying Anxiety and stress cause sweating and there is more body water loss The recirculated air on airplanes has 20-30% less moisture in it Air conditioning and sitting actually cause body temperature to rise, and people sweat more but the cool...

Mistletoe (Viscum Album) is a plant that lives on trees, such as apple, oak, maple, elm, pine, and birch. It is native to Europe and Western Asia. Viscum album has been used for centuries. Brand names for this plant include Helixor®, Iscador®, Iscador Qu®, Lektinol™, Cefalektin®, Eurixor®, ABNOBAviscum® and Abnoba-viscum Quercust. Mistletoe is given either through subcutaneous injection or intravenously. The extracts of this plant, specifically the one that grows on pine trees, are currently being studied in cancer patients. In clinical studies, mistletoe has been demonstrated  to be safe and effective along with conventional treatment such as chemotherapy and radiation. Mistletoe therapy has been studied and used at top level cancer research centers such as Sloan-Kettering Cancer Institute in John Hopkins, among just a few. In addition to stimulating the bone marrow it may be used to decrease side effects of chemo and radiation. In our complimentary and integrative oncology center, attention is devoted principally to the aspects of quality of life, prolonging survival, and preventing relapse. Mistletoe at Work in the Body The body’s own defenses are strengthened by mistletoe therapy in such a way that beneficial granulocytes, lymphocytes, and natural killer cells increase. Any degenerated cells still...

EDTA (ethylene diamine tetra-acetic acid) is an amino acid that is FDA approved for lead poisoning and used as an alternative treatment for heart disease caused by atherosclerosis. It is not yet approved by the FDA for the use in cardiovascular conditions, but this may occur soon. Safety concerns in the past included low hypocalcemia (low calcium).  Patients with severe kidney disease cannot tolerate normal doses. The side effect of hypocalcemia is only seen with a specific type of EDTA called disodium EDTA which is not used anymore in doctors’ offices. Calcium EDTA is the type of EDTA now used. It can be infused extremely rapidly with no effect on blood calcium levels. Disodium EDTA has to be infused slowly because of its effect on calcium. Hypocalcemia can cause cramping and heart arrhythmias so it was a legitimate concern in the past. Is There Evidence that Chelation is Effective? A 2012 clinical trial called the Trial to Assess Chelation Therapy (TACT) attempted to answer this question. This clinical trial was done with people who have had heart attacks, as well as those with diabetes. It’s the first large-scale, multi-center clinical trial of its kind. In this trial 1,700 patients were...